Impact of tacrolimus on bone metabolism after kidney transplantation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Immunopharmacology

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.intimp.2012.03.019PMID 22469633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation.

  2011cited by this paper
• Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease.

  2011cited by this paper
• Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

  2011cited by this paper
• Optimizing bone health in chronic kidney disease.

  2010cited by this paper
• Bone disease after renal transplantation

  2010cited by this paper
• Immunosuppressant FK506 decreases the intracellular magnesium in the human osteoblast cell by inhibiting the ERK1/2 pathway.

  2009cited by this paper
• Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation

  2009cited by this paper
• Osteoporosis and related risk factors in renal transplant recipients.

  2009cited by this paper
• Tacrolimus-Induced Elevation in Plasma Triglyceride Concentrations After Administration to Renal Transplant Patients Is Partially Due to a Decrease in Lipoprotein Lipase Activity and Plasma Concentrations

  2009cited by this paper
• Effect of low-dose tacrolimus coadministered with raloxifene on the skeletal system in male rats.

  2009cited by this paper
• Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density

  2009cited by this paper
• Utility of serum tartrate‐resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

  2008cited by this paper
• Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.

  2008cited by this paper
• Lumbar Bone Mineral Density in Renal Transplant Patients on Neoral and Tacrolimus: A Four-Year Prospective Study

  2006cited by this paper
• Late Low‐Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density

  2006cited by this paper
• Long-term problems related to immunosuppression.

  2006cited by this paper
• Characterisation of cytosolic FK506 binding protein 12 and its role in modulating expression of Cbfa1 and osterix in ROS 17/2.8 cells.

  2005cited by this paper
• Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.

  2004cited by this paper
• Regulation of bone metabolism in immunosuppressant (FK506)-treated rats

  2004cited by this paper
• Osteoporosis after renal transplantation.

  2003cited by this paper
• Bone mineral density and fracture prevalence in long-term kidney graft recipients

  2002cited by this paper
• Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.

  1995cited by this paper

• Survivorship and Outcomes of Hip Arthroplasty for Elective Care Versus Fracture in Patients Who Have Solid Organ Transplant: Lung Transplant Patients Do Worse.

  2025cites this paper
• Current Concept Review: Medication-Related Impacts on Pediatric Bone Health

  2025cites this paper
• Medication-induced Fractures: Screening and Treatment Strategies.

  2024cites this paper
• Clinical Significance of Incident Osteoporotic Fractures After Kidney Transplantation: A National Korean Cohort Study.

  2024cites this paper
• The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial

  2022cites this paper
• Potential Privilege of Maltodextrin-α-Tocopherol Nano-Micelles in Seizing Tacrolimus Renal Toxicity, Managing Rheumatoid Arthritis and Accelerating Bone Regeneration

  2021cites this paper
• Parathyroidectomy Protects Against Pathologic Fractures After Kidney Transplantation: Results From a Retrospective Single-center Trial

  2021cites this paper
• Posttransplant Bone Loss

  2020cites this paper
• Kidney Transplantation

  2019cites this paper
• Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice?

  2018cites this paper
• CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health

  2017cites this paper
• MicroRNA expression analysis during FK506-induced osteogenic differentiation in rat bone marrow stromal cells

  2017cites this paper
• Osteoporosis in Organ Transplant Patients

  2016cites this paper
• Intérêt de l’évaluation de la texture osseuse par le Trabecular Bone Score (TBS) chez les patients transplantés rénaux

  2015cites this paper
• Fifty shades of gray: Bone disease in renal transplantation

  2015cites this paper
• PROFESSEURS DES UNIVERSITES - PRATICIENS HOSPITALIERS

  2015cites this paper
• Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management

  2015cites this paper
• Drugs that act on the immune system

  2014cites this paper
• Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs

  2014cites this paper
• FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2013cites this paper
• Persistence of Bone and Mineral Disorders 2 Years After Successful Kidney Transplantation

  2013cites this paper